HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Integra LifeSciences (IART) Investors with Substantial Losses and Persons Who May Assist in Firm’s Investigation into Global Recall and Possible Securities Law Violations to Contact Firm’s Attorneys


SAN FRANCISCO, June 26, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Integra LifeSciences Holdings Corp. (NASDAQ: IART) investors who suffered substantial losses to submit your losses now.

Visit: www.hbsslaw.com/investor-fraud/IART
Contact An Attorney Now: IART@hbsslaw.com
844-916-0895

Integra LifeSciences Holdings Corp. (IART) Investigation:

The investigation focuses on Integra’s assurances that it complies with Good Manufacturing Practices.

On May 23, 2023, Integra announced that, after an internal investigation, it initiated a global recall of all products manufactured in its Boston, Mass. facility distributed between Mar. 1, 2018 and May 22, 2023 and halted manufacturing at the facility. The company explained that it “identified deviations with endotoxin testing that may have resulted in the release of products with higher levels of endotoxins than permitted by the product specifications.”

Integra further revealed that it expects to incur a material impairment charge related to the write-off of inventories. As a result of these moves, Integra significantly lowered its revenue and EPS guidance.

This news drove the price of Integra shares crashing lower on May 23, 2023.

“We’re focused on investors’ losses and whether Integra misled investors about its compliance with worldwide Good Manufacturing Practices,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Integra and have substantial losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Integra should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email IART@hbsslaw.com.

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895